Symptoms free-days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …"

Diarrhea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …"

Nausea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …"

Cough-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …"

Dyspnea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …"

LPS decreases only T cell proliferative response to OKT3. حسب Fanny Poujol (834338)

Sodium levels (mg/100 g) in matched restaurant menu items in 2016 and 2020 by UK NSRI food categories with ≥ 10 items. حسب Caroline G. Middleton (22041479)

Overexpression of Lethe in RAW macrophage cells decreases ROS production. حسب Carlos Zgheib (311460)

UVB irradiation decreased TM expression in HaCaT cells. حسب Huey-Chun Huang (429098)

"…<p>(A) HaCaT Cells were exposed to UVB irradiation in a dose-response (0, 1.5, 3, 4.5, 6 mJ/cm²) Cell viability was examined by trypan blue exclusion. …"

The utility of Hmp for NO• consumption and tolerance decreases with increased NO• delivery rate. حسب Jonathan L. Robinson (409406)

Zinc exposure decreases NR1 clusters and NMDA currents. حسب Jia Zhu (135506)

"…(B) and (C) show the quantification of (A). Both the number and mean intensity of NR1 clusters were significantly decreased after zinc treatment. …"

OPN-deficiency decreases HFD-induced liver inflammation and fibrosis. حسب Andoni Lancha (335824)

Increased data compression and variability with decreasing spot TD intensity حسب Xujing Wang (21247)

Hepatic steatosis was dramatically decreased in CD44KO(HFD). حسب Hong Soon Kang (386679)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. حسب Jesse M. Gray (527662)

"…<p>(<b>A</b>) Genome-wide expression of 5′ splice sites, 3′ splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 µM, 18 hours), based on total RNA-Seq (dUTP method <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone.0089673-Parkhomchuk1" target="_blank">[18]</a>, Illumina). …"

Poly (I:C) decreases HIV-1 replication in PBMCs. حسب Christiane Rollenhage (762318)

Transgenic expression of SPDEF in prostate epithelium decreased prostate carcinogenesis. حسب Xin-Hua Cheng (154368)

"…Data represent mean ± SD. A <i>p</i> value<0.01 is shown with (**) and <i>p</i> value<0.05 is shown with (*). …"

A chronic high glucose treatment decreases proteasome activities and increases apoptosis in human islets. حسب Christophe Broca (538652)

Decreased cell viability and ROS production induced by oxidative treatment. حسب Sandra M. Martín-Guerrero (780940)

AICAR-activated AMPK decreased SREBP-2 protein levels. حسب Shudong Liu (733425)